Vol 79, No 12 (2021)
Original article
Published online: 2021-10-08

open access

Page views 7803
Article views/downloads 1701
Get Citation

Connect on Social Media

Connect on Social Media

Pulmonary embolism response team: A multidisciplinary approach to pulmonary embolism treatment. Polish PERT Initiative Report

Aleksander Araszkiewicz1, Marcin Kurzyna2, Grzegorz Kopeć34, Sylwia Sławek-Szmyt1, Katarzyna Wrona2, Jakub Stępniewski34, Stanisław Jankiewicz1, Arkadiusz Pietrasik5, Michał Machowski6, Szymon Darocha2, Tatiana Mularek-Kubzdela1, Adam Torbicki2, Piotr Pruszczyk6, Marek Roik6
Pubmed: 34643260
Kardiol Pol 2021;79(12):1311-1319.

Abstract

Background: A pulmonary embolism response team (PERT) is a multidisciplinary team established to improve clinical care for patients with pulmonary embolism (PE). However, data regarding detailed institutional experience and clinical outcomes from such teams are sparse.
Aims: We aim to assess the frequency of activations, patients’ characteristics, PE severity, applied treatments, and outcomes of PE patients treated by Polish PERTs.
Methods: The survey registry was conducted between June 2018 and July 2020. All consecutive PERT activations of four institutionalized PERTs in Poland were analyzed. Patients’ characteristics, therapies applied, and in-hospital outcomes were evaluated.
Results: There were 680 unique PERT activations. Most activations originated from Emergency Departments (44.9%), and the remaining originated from internal medicine/cardiology units (31.1%), surgery/orthopedics (9.1 %), oncology (6.3%), intensive care units (6.0%), and others (2.5%). The origin of activation varied significantly among institutions (P <0.01). Most PERT cases were patients with intermediate-high risk PE (42.9%), whereas high-risk PE occurred in 10% of patients. Anticoagulation alone was delivered to 80.3% of patients, and 23.3% of patients received at least one advanced therapy: catheter-directed therapies (11.3%), systemic thrombolysis (5.3%), surgical embolectomy (2.4%), vena cava filter placement (3.7%), and extracorporeal membrane oxygenation (0.6%). In-hospital mortality in the whole study group was 5.1%, with significant differences between institutions (P = 0.01).
Conclusions: The frequency of PE severity, type of delivered catheter-directed treatment, and in-hospital mortality vary between institutions without significant discrepancies in PERT activations. This variation between expert centers highlights the local differences in PERTs’ organizational and operational forms.

References

  1. Cohen AT, Agnelli G, Anderson FA, et al. VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007; 98(4): 756–764.
  2. Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet. 2012; 379(9828): 1835–1846.
  3. Konstantinides SV, Meyer G, Becattini C, et al. The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J. 2019; 54(3): 1901647.
  4. Goldhaber SZ, Haire WD, Feldstein ML, et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet. 1993; 341(8844): 507–511.
  5. Schultz J, Andersen A, Kabrhel C, et al. Catheter-based therapies in acute pulmonary embolism. EuroIntervention. 2018; 13(14): 1721–1727.
  6. Iaccarino A, Frati G, Schirone L, et al. Surgical embolectomy for acute massive pulmonary embolism: state of the art. J Thorac Dis. 2018; 10(8): 5154–5161.
  7. Meneveau N, Guillon B, Planquette B, et al. Outcomes after extracorporeal membrane oxygenation for the treatment of high-risk pulmonary embolism: a multicentre series of 52 cases. Eur Heart J. 2018; 39(47): 4196–4204.
  8. Borowiec A, Kurnicka K, Zieliński D, et al. Acute pulmonary embolism and right atrial thrombus as a complication of the central venous access port device for the delivery of chemotherapy. Kardiol Pol. 2020; 78(7-8): 778–779.
  9. Pruszczyk P, Konstantinides S. Where to treat patients with acute pulmonary embolism? Kardiol Pol. 2020; 78(1): 15–19.
  10. Schultz J, Giordano N, Zheng H, et al. EXPRESS: a Multidisciplinary Pulmonary Embolism Response Team (PERT) — experience from a national multicenter consortium. Pulm Circ. 2019 [Epub ahead of print]: 2045894018824563.
  11. Kabrhel C, Jaff MR, Channick RN, et al. A multidisciplinary pulmonary embolism response team. Chest. 2013; 144(5): 1738–1739.
  12. Dudzinski DM, Piazza G. Multidisciplinary pulmonary embolism response teams. Circulation. 2016; 133(1): 98–103.
  13. Romano KR, Cory JM, Ronco JJ, et al. Vancouver General Hospital Pulmonary Embolism Response Team (VGH PERT): initial three-year experience. Can J Anaesth. 2020; 67(12): 1806–1813.
  14. Rosovsky R, Chang Y, Rosenfield K, et al. Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis. J Thromb Thrombolysis. 2019; 47(1): 31–40.
  15. Provias T, Dudzinski DM, Jaff MR, et al. The Massachusetts General Hospital Pulmonary Embolism Response Team (MGH PERT): creation of a multidisciplinary program to improve care of patients with massive and submassive pulmonary embolism. Hosp Pract (1995). 2014; 42(1): 31–37.
  16. Kabrhel C, Rosovsky R, Channick R, et al. a multidisciplinary pulmonary embolism response team: initial 30-month experience with a novel approach to delivery of care to patients with submassive and massive pulmonary embolism. Chest. 2016; 150(2): 384–393.
  17. Stępniewski J, Kopeć G, Musiałek P, et al. Hemodynamic effects of ultrasound-assisted, catheter-directed, very low-dose, short-time duration thrombolysis in acute intermediate–high risk pulmonary embolism (from the EKOS-PL study). Am J Cardiol. 2021; 141: 133–139.
  18. Roik M, Wretowski D, Łabyk A, et al. Initial experience of pulmonary embolism response team with percutaneous embolectomy in intermediate-high- and high-risk acute pulmonary embolism. Kardiol Pol. 2019; 77(2): 228–231.
  19. Sławek-Szmyt S, Jankiewicz S, Smukowska-Gorynia A, et al. Implementation of a regional multidisciplinary pulmonary embolism response team: PERT-POZ initial 1-year experience. Kardiol Pol. 2020; 78(4): 300–310.
  20. Araszkiewicz A, Kurzyna M, Kopeć G, et al. Expert opinion on the creating and operating of the regional Pulmonary Embolism Response Teams (PERT). Polish PERT Initiative. Cardiol J. 2019; 26(6): 623–632.
  21. Araszkiewicz A, Sławek-Szmyt S, Jankiewicz S, et al. Continuous aspiration thrombectomy in high- and intermediate-high-risk pulmonary embolism in real-world clinical practice. J Interv Cardiol. 2020; 2020: 4191079.
  22. Schulman S, Kearon C. Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005; 3(4): 692–694.
  23. Roik M, Wretowski D, Machowski M, et al. Successful treatment of intermediate-high-risk pulmonary embolism with aspiration thrombectomy: first experience in Poland. Kardiol Pol. 2018; 76(9): 1381.
  24. Araszkiewicz A, Jankiewicz S, Sławek-Szmyt S, et al. Rapid clinical and haemodynamic improvement in a patient with intermediate-high risk pulmonary embolism treated with transcatheter aspiration thrombectomy. Postepy Kardiol Interwencyjnej. 2019; 15(4): 497–498.
  25. Khaing P, Paruchuri A, Eisenbrey JR, et al. First year experience of a pulmonary embolism response team with comparisons of outcomes between catheter directed therapy versus standard anticoagulation. Hosp Pract (1995). 2020; 48(1): 23–28.
  26. Xenos ES, Davis GA, He Q, et al. The implementation of a pulmonary embolism response team in the management of intermediate- or high-risk pulmonary embolism. J Vasc Surg Venous Lymphat Disord. 2019; 7(4): 493–500.
  27. Rivera-Lebron B, McDaniel M, Ahrar K, et al. PERT Consortium. Diagnosis, treatment and follow up of acute pulmonary embolism: consensus practice from the PERT consortium. Clin Appl Thromb Hemost. 2019; 25: 1076029619853037.
  28. Mahar JH, Haddadin I, Sadana D, et al. A pulmonary embolism response team (PERT) approach: initial experience from the Cleveland Clinic. J Thromb Thrombolysis. 2018; 46(2): 186–192.
  29. Budaj-Fidecka A, Kurzyna M, Fijałkowska A, et al. ZATPOL Registry Investigators. In-hospital major bleeding predicts mortality in patients with pulmonary embolism: an analysis of ZATPOL Registry data. Int J Cardiol. 2013; 168(4): 3543–3549.
  30. Fijałkowska A, Szczerba E, Szewczyk G, et al. Investigators ZATPOL Registry. Pregnancy as a predictor of deviations from the recommended diagnostic pathway in women with suspected pulmonary embolism: ZATPOL registry data. Arch Med Sci. 2018; 14(4): 838–845.
  31. Chaudhury P, Gadre SK, Schneider E, et al. Impact of multidisciplinary pulmonary embolism response team availability on management and outcomes. Am J Cardiol. 2019; 124(9): 1465–1469.
  32. Aharoni M, Horesh N, Rogowski O, et al. Unprovoked pulmonary embolism in older adults: incidence and prognosis. Arch Med Sci. 2021; 17(2): 337–342.